In breast cancer and pancreatic ductal adenocarcinoma, iCAFs influence the immunosuppressive microenvironment by secreting inflammatory factors such as IL-6 [37, 38]. This evidence concerns the gene IL6 and pancreatic ductal adenocarcinoma.